Results 91 to 100 of about 5,040 (223)

Postoperative Fluoroscopic Appearance After Flexible Endoscopic Zenker's Diverticulotomy

The Laryngoscope, Volume 135, Issue 11, Page 4155-4161, November 2025.
We perform a retrospective study on patients undergoing flexible Zenker's diverticulotomy surgery and report changes in the objective fluoroscopic appearance as well as patient‐reported outcome measures. ABSTRACT Objective Flexible approach to treating Zenker's diverticulum (ZD) has gained traction in recent years. However, objective measures comparing
Shumon I. Dhar, Savannah E. Lukkes, Eric Allen, Aniah Jefferson, Rishi Suresh, Maggie A. Kuhn, Lisa M. Evangelista, Daniel J. Cates   +7 more
wiley   +1 more source

Prognosis in hypertrophic cardiomyopathy observed in a large clinic population [PDF]

, 1993
Overall annual cardiac mortality in hypertrophic cardiomyopathy (HC) has been reported to be between 2 and 4%, although these numbers are primarily from retrospective studies of patients referred to large research institutions. A clinic population of 113
Cate, F.J. (Folkert) ten, Kofflard, M.J.M. (Marcel), Vos, J. (Jeroen), Waldstein, D.J.   +3 more
core   +1 more source

Does Left Atrial Size and E/e′ Predict Outcomes in Hypertrophic Cardiomyopathy?

Echocardiography, Volume 42, Issue 11, November 2025.
The current study followed 233 patients with hypertrophic cardiomyopathy, over a median follow‐up of 8 years. Left atrial size but not E/e' were predictive of outcomes related to atrial arrhythmia, and none were predictive of all‐cause mortality in multivariate analysis.
Brandon Tillson, Stephen Lord, Christopher Eggett   +2 more
wiley   +1 more source

Septal myectomy for hypertrophic obstructive cardiomyopathy: coil, boil and the role of rescue surgery [PDF]

, 2017
Interventional treatment of hypertrophic obstructive cardiomyopathy has considerably developed and primary surgical approach is nowadays considered for a minority of patients with insufficient relief of obstruction following catheter intervention.
Carrel, Thierry, Schmidli, Jürg
core  

3D printing is a transformative technology in congenital heart disease [PDF]

, 2018
Survival in congenital heart disease has steadily improved since 1938, when Dr. Robert Gross successfully ligated for the first time a patent ductus arteriosus in a 7-year-old child.
Anwar, Anwar, Barach, Bernhard, Bhatla, Biglino, Biglino, Binder, Boneva, Borrello, Botto, Brown, Bucher, Byrne, Chaowu, Conti, Costello, Dearani, Deferm, Duan, Duan, Erikssen, Fan, Farooqi, Farooqi, Farooqi, Fleming, Fukunishi, Garekar, Gaynor, Gentles, Giamberti, Giannopoulos, Giroud, Gosnell, Grant, Green, Hadeed, Hermsen, Hoffman, Holst, Holst, Hu, Jacobs, Jana, Javan, Jonas, Kappetein, Kapur, Khairy, Kiraly, Kirklin, Kolli, Kotsis, Kung, Lee, Lee, Little, Lloyd-Jones, Mahle, Mahmood, Mannoor, Maragiannis, Markert, Markstedt, Mashari, Meier, Michael, Mitsouras, Moons, Moore, Morrison, Muraru, Ngan, Noecker, Olivieri, Olivieri, O’Brien, O’Neill, Pentecost, Poterucha, Randazzo, Rehder, Riesenkampff, Ripley, Rodriguez-Paz, Ryan, Saeed, Samuel, Santos dos, Schievano, Schmauss, Shah, Smith, Sodian, Sodian, Sutcliffe, Tabriz, Tack, Taylor, Valverde, VanKoevering, Vukicevic, Vukicevic, Vukicevic, Wang, Wang, Warnes, Warnes, Warnes, Whitlock, Wilasrusmee, Williams, Witschey, Yoo, Yoo, Zopf, Zweifel   +117 more
core   +3 more sources

Commentary: Cox maze with septal myectomy [PDF]

The Journal of Thoracic and Cardiovascular Surgery, 2021
Harold G, Roberts, Lawrence M, Wei, Vinay, Badhwar   +2 more
openaire   +2 more sources

Endocardial septal ablation for hypertrophic obstructive cardiomyopathy

Türk Kardiyoloji Derneği Arşivi, 2017
Summary– Septal reduction therapy (SRT) is the accepted therapeutic option for symptomatic hypertrophic obstructive cardiomyopathy (HOCM). At this time, surgical septal myectomy is the gold standard method, but alcohol septal ablation is an acceptable ...
Tolga Aksu, Tümer Erdem Güler, Kıvanç Yalın, Şükriye Ebru Gölcük, Kazım Serhan Özcan   +4 more
doaj   +1 more source

Valsartan for attenuating disease evolution in early sarcomeric hypertrophic cardiomyopathy: the design of the Valsartan for Attenuating Disease Evolution in Early Sarcomeric Hypertrophic Cardiomyopathy (VANISH) trial [PDF]

, 2017
Background: Hypertrophic cardiomyopathy (HCM) is often caused by sarcomere gene mutations, resulting in left ventricular hypertrophy (LVH), myocardial fibrosis, and increased risk of sudden cardiac death and heart failure.
Braunwald, Eugene, Cirino, Allison L., Colan, Steven D., Day, Sharlene M., Desai, Akshay S., Ho, Carolyn Y., Lipshultz, Steven E., MacRae, Calum A., McMurray, John J.V., Orav, E. John, Shi, Ling, Solomon, Scott D.   +11 more
core   +1 more source

Two‐Year Results of Percutaneous Endocardial Septal Radiofrequency Ablation for Hypertrophic Obstructive Cardiomyopathy

Catheterization and Cardiovascular Interventions, Volume 106, Issue 4, Page 2763-2769, October 1, 2025.
ABSTRACT Background Hypertrophic obstructive cardiomyopathy (HOCM) is a hereditary myocardial disease. Percutaneous endocardial septal radiofrequency ablation (PESA) is an innovative approach for treating HOCM. Consequently, we present the outcomes of the PESA for HOCM. Methods This study included 20 patients with HOCM who received PESA.
NingNing Zheng, YiYuan Chen, YongBing Fu, Feng Xue, FangFang Zhang, Lin Ling, TingBo Jiang   +6 more
wiley   +1 more source

Lower left ventricular ejection time in MYBPC3 variant carriers with overt or subclinical hypertrophic cardiomyopathy

ESC Heart Failure, Volume 12, Issue 5, Page 3416-3425, October 2025.
Abstract Aims Hypertrophic cardiomyopathy (HCM) is an inherited cardiomyopathy often caused by pathogenic variants in MYBPC3 and MYH7, encoding myosin‐binding protein C3 and myosin heavy chain 7, respectively. These variants can cause increased actin–myosin crossbridge cycling, resulting in ventricular hypercontractility, but mice lacking Mybpc3 ...
Isabell Yan, Zoe Möhring, Daniel Reichart, Fanny Kortüm, Julia Münch, Rixa Woitschach, Paulus Kirchhof, Lucie Carrier, Carolyn Y. Ho, Thomas Eschenhagen, Monica Patten   +10 more
wiley   +1 more source